These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 3733203)
1. Seroepidemiological study to determine age for measles vaccination. Bhaskaram P; Radhakrishna KV; Madhusudan J Indian J Med Res; 1986 May; 83():480-6. PubMed ID: 3733203 [No Abstract] [Full Text] [Related]
2. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine]. Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095 [No Abstract] [Full Text] [Related]
3. The role of herd immunity in control of measles. Black FL Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027 [TBL] [Abstract][Full Text] [Related]
4. [The study of countermeasures on measles control in infants]. Wang L; Sun L; Jiang Z; Kang S; Liu Y; Jiang X Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):49-50. PubMed ID: 11860845 [TBL] [Abstract][Full Text] [Related]
5. Two studies on optimal timing for measles vaccination. Riedmann EM Hum Vaccin Immunother; 2013 Dec; 9(12):2499. PubMed ID: 24322739 [No Abstract] [Full Text] [Related]
6. Letter to the editor. Spotlight on measles 2010: timely administration of the first dose of measles vaccine in the context of an ongoing measles outbreak in France. Gagneur A; Pinquier D Euro Surveill; 2010 Oct; 15(41):19689; author reply 19686. PubMed ID: 20961512 [No Abstract] [Full Text] [Related]
8. Appropriate age for measles vaccination in the United States. Orenstein WA; Markowitz L; Preblud SR; Hinman AR; Tomasi A; Bart KJ Dev Biol Stand; 1986; 65():13-21. PubMed ID: 3549395 [TBL] [Abstract][Full Text] [Related]
9. [Immuno-epidemiologic considerations on the prevention of measles in Mexico]. Díaz-Ortega JL; Valdespino-Gómez JL; Zárate-Aquino ML; Camacho-Amor ML; González-Velázquez MS; Chávez-San Juan R Bol Med Hosp Infant Mex; 1990 Jul; 47(7):474-81. PubMed ID: 2206412 [TBL] [Abstract][Full Text] [Related]
10. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era. Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581 [TBL] [Abstract][Full Text] [Related]
11. Rural Kenya: measles during pregnancy and early infancy. Arya SC; Agarwal N J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147 [No Abstract] [Full Text] [Related]
12. Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns. Leuridan E; Van Damme P Vaccine; 2007 Aug; 25(34):6296-304. PubMed ID: 17629601 [TBL] [Abstract][Full Text] [Related]
13. [Epidemiologic and clinical effect of measles vaccination in Karl-Marx City District. II]. Hajduk F; Starke G; Grimm J Dtsch Gesundheitsw; 1970 Oct; 25(44):2095-6. PubMed ID: 5491297 [No Abstract] [Full Text] [Related]
14. [Measles vaccination with split vaccines and living vaccines (author's transl)]. Stehr K; Enders-Ruckle G; Spiess H MMW Munch Med Wochenschr; 1975 Jul; 117(27):1159-64. PubMed ID: 808710 [TBL] [Abstract][Full Text] [Related]
15. Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age. De Serres G; Boulianne N; Defay F; Brousseau N; Benoît M; Lacoursière S; Guillemette F; Soto J; Ouakki M; Ward BJ; Skowronski DM Clin Infect Dis; 2012 Aug; 55(3):394-402. PubMed ID: 22543023 [TBL] [Abstract][Full Text] [Related]
16. [Measles immunization and its problems]. Kökkaya A Mikrobiyol Bul; 1982 Jan; 16(1):66-70. PubMed ID: 7144618 [TBL] [Abstract][Full Text] [Related]